Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ayme

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Annales De Chirurgie|January 1, 1995
[Conservative treatment of sub-clinical noninfiltrating cancers of the breast (102 EOA in situ, TONO)]H Brandone, Y Ayme, D Hans, et al.
La Clinica Terapeutica|August 1, 1994
[2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients]E Garcia-Giralt, C Omodei Zorini, L Ferri, et al.
World Journal of Surgery|December 1, 1986
Breast-conserving surgery with radiation therapy for operable mammary carcinoma: a 25-year experienceJ M Spitalier, J Gambarelli, H Brandone, et al.
Bulletin Du Cancer|January 1, 1991
[Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk]P M Martin, S Romain, F Spyratos, et al.
Journal De Chirurgie|November 1, 1987
[Breast cancer: prognostic factors. Apropos of 1000 conservative treatments]D Hans, C Bressac, R Amalric, et al.
Strahlentherapie|April 1, 1984
Radiation therapy after breast-conserving surgery for Stage I and II mammary carcinoma. Results of the Marseille experience 1961 to 1976J M Kurtz, R Amalric, F Santamaria, et al.
Seminars in Oncology|April 1, 1989
Navelbine in advanced ovarian epithelial cancer: a study of the French oncology centersM J George, J F Heron, P Kerbrat, et al.
Cancer|May 15, 1989
Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosisJ M Kurtz, R Amalric, H Brandone, et al.
Cancer|January 1, 1982
Radiation therapy with or without primary limited surgery for operable breast cancer: a 20-year experience at the Marseilles Cancer InstituteR Amalric, F Santamaria, F Robert, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Annales De Chirurgie|January 1, 1995
[Conservative treatment of sub-clinical noninfiltrating cancers of the breast (102 EOA in situ, TONO)]H Brandone, Y Ayme, D Hans, et al.
La Clinica Terapeutica|August 1, 1994
[2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients]E Garcia-Giralt, C Omodei Zorini, L Ferri, et al.
World Journal of Surgery|December 1, 1986
Breast-conserving surgery with radiation therapy for operable mammary carcinoma: a 25-year experienceJ M Spitalier, J Gambarelli, H Brandone, et al.
Bulletin Du Cancer|January 1, 1991
[Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk]P M Martin, S Romain, F Spyratos, et al.
Journal De Chirurgie|November 1, 1987
[Breast cancer: prognostic factors. Apropos of 1000 conservative treatments]D Hans, C Bressac, R Amalric, et al.
Strahlentherapie|April 1, 1984
Radiation therapy after breast-conserving surgery for Stage I and II mammary carcinoma. Results of the Marseille experience 1961 to 1976J M Kurtz, R Amalric, F Santamaria, et al.
Seminars in Oncology|April 1, 1989
Navelbine in advanced ovarian epithelial cancer: a study of the French oncology centersM J George, J F Heron, P Kerbrat, et al.
Cancer|May 15, 1989
Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosisJ M Kurtz, R Amalric, H Brandone, et al.
Cancer|January 1, 1982
Radiation therapy with or without primary limited surgery for operable breast cancer: a 20-year experience at the Marseilles Cancer InstituteR Amalric, F Santamaria, F Robert, et al.
Pageof 5